SEC Filing Details
Document Details
Form
Filing Date
May 30, 2024
Document Date
May 30, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
CRISPR Therapeutics
Issuer
CRISPR Therapeutics AG
Filer
Mahatme Sandesh